NVOH
Novo Nordisk A/S (B Shares) ADRhedged·ARCA
--
--(--)
--
--(--)
Key Stats
Assets Under Management
2.53MUSD
Fund Flows (1Y)
--
Dividend Yield
2.37%
Discount/Premium to NAV
--
Shares Outstanding
--
Expense Ratio
0.19%
About Novo Nordisk A/S (B Shares) ADRhedged
Issuer
Precidian Funds LLC
Brand
ADRhedged
Inception Date
Jan 2, 2025
Structure
Open-Ended Fund
Index Tracked
--
Management Style
Active
Dividend Treatment
Distributes
Distribution Tax Treatment
Ordinary income
Income Tax Type
Capital Gains
Max ST Capital Gains Rate
39.60%
Max LT Capital Gains Rate
20.00%
Primary Advisor
--
Distributor
Foreside Fund Services LLC
NVOH provides exposure to currency-hedged depositary receipt for Americans interested in investing in Novo Nordisk A/S (B Shares). Investing in the ADR or original shares directly exposes investors currency fluctuations, which impacts returns. ADRhedged products aim to provide a slightly different approach to international investing by focusing on a single international stock and hedging the specific currency risk. It is anticipated that each ETF share will represent one ADR share. In addition, each day a currency hedge contract is marked to the market based on the notional value of the currency hedge contract and the change in the value of the local currency in relation to the US dollar. As a result of the market-to-market payments, the ratio of portfolio securities to shares will vary over time. The objective is to provide the total return performance of the stock in its local market.
Classification
Asset Class
Equity
Category
Sector
Focus
Health Care
Niche
Pharmaceuticals
Strategy
Vanilla
Geography
--
Weighting Scheme
Single Asset
Selection Criteria
Single asset
Analysis
Asset
Holdings
Symbol
Ratio
NVO
98.97%
Cash(US$)
1.03%
Symbol
Ratio
No holdings data
Top 10 Weight 100%
2 Total Holdings
See all holdings
Related Funds
Seasonals
Volume Profile
Trade Flow Insight
Community Forum
Loading...
Related News
No articles available
You can ask Aime
No Data
